相关实验视频
Updated: Jun 21, 2025

10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
21.6K
萨尔维阿诺酸B抑制了血栓形成,并直接阻断了血栓催化部位
Miguel A D Neves1,2,3,4, Tiffany T Ni1,2,3, Daniel T Mackeigan2,3,5
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Research and practice in thrombosis and haemostasis
|July 12, 2024
概括
萨尔维阿诺酸B (SAB) 直接抑制血栓,减少血块的形成. 这种来自草药的化合物可能为动脉和深静脉血栓形成提供一种具有成本效益的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 传统中国医药 传统中国医药
背景情况:
- 萨尔维亚诺酸B (SAB) 是Salvia miltiorrhiza (Danshen) 的一个关键成分,历史上用于心血管疾病.
- 在中国,富含SAB的丹申酸盐已被批准用于治疗慢性心肌痛.
- 临床使用表明Danshen可以抑制血栓形成,但机制尚不清楚.
研究的目的:
- 阐明沙尔维亚诺酸B (SAB) 的抗血栓机制.
主要方法:
- 采用了血小板聚合,凝血试验, perfusion 室和静脉内显微镜.
- 用酶分析,光光谱测量和异热定位热量计来确定ombin抑制动力学和结合亲和力.
- 在基分子对接中预测了SAB与血栓激素活性部位的相互作用.
主要成果:
- 剂量依赖的SAB抑制了由血栓激发的血小板激活和聚合,也影响了ADP和原诱导的聚合.
- 通过改变纤维素网络,SAB减弱了血液凝结,并在体内和体外减少了血栓形成.
- 证实了SAB和血之间的直接相互作用,分子对接表明它与活性部位结合,类似于达比加特兰.
结论:
- SAB被确定为第一个由草药衍生的直接激素催化部位抑制剂.
- SAB通过依赖血栓和独立途径抑制血栓形成.
- 纯化SAB为动脉和深静脉血栓形成提供了潜在的经济有效的治疗方法.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
486
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
486
Antihypertensive Drugs: Action of Calcium Channel Blockers
493
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
493

